{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:11:28Z","timestamp":1790071888457,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ejphar.2015.01.044","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T16:41:30Z","timestamp":1423327290000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats"],"prefix":"10.1016","volume":"752","author":[{"given":"Hala S.","family":"Abdel Kawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2015.01.044_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1665-2681(19)31400-0","article-title":"First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder","volume":"12","author":"Al Nahdi","year":"2013","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib2","series-title":"Theory and Practice of Histological Techniques","volume":"vol. 121","author":"Bancroft","year":"2008"},{"issue":"7","key":"10.1016\/j.ejphar.2015.01.044_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/CS20120052","article-title":"Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis","volume":"124","author":"Chang","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2015.01.044_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"Czochra","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2015.01.044_bib6","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2013 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.ejphar.2015.01.044_bib7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/gut.2007.144550","article-title":"Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease","volume":"57","author":"Fujita","year":"2008","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejphar.2015.01.044_bib8","first-page":"70","article-title":"Serum markers of liver fibrogenesis, and liver histology findings in patients with chronic liver diseases","volume":"103","author":"Holoman","year":"2002","journal-title":"Bratisl. Lek. Listy"},{"issue":"1","key":"10.1016\/j.ejphar.2015.01.044_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.106.101444","article-title":"Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression","volume":"318","author":"Gao","year":"2006","journal-title":"J Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2015.01.044_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/019262339602400105","article-title":"Importance of and approaches to quantification of hepatocyte apoptosis","volume":"24","author":"Goldsworthy","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0168-8278(99)80169-X","article-title":"Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats","volume":"31","author":"Grappone","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.regpep.2011.04.010","article-title":"Aldosterone induction of hepatic stellate cell contraction through activation of RhoA\/ROCK-2 signaling pathway","volume":"169","author":"Ji","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2015.01.044_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.LAB.0000054178.01162.E4","article-title":"The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis","volume":"83","author":"Kinnman","year":"2003","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ejphar.2015.01.044_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bpg.2011.02.011","article-title":"Anti-fibrogenic strategies and the regression of fibrosis","volume":"25","author":"Kisseleva","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.01.044_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4196\/kjpp.2012.16.2.131","article-title":"Cilostazol decreases ethanol-mediated TNFalpha expression in RAW264.7 murine macrophage and in liver from binge drinking mice","volume":"16","author":"Lee","year":"2012","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib17","first-page":"F3","article-title":"Phosphodiesterase activity as a mediator of renal resistance to ANP in pathological salt retention","volume":"271","author":"Lee","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"42","key":"10.1016\/j.ejphar.2015.01.044_bib18","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.3748\/wjg.15.5326","article-title":"Usefulness of a scoring system in the interpretation of histology in neonatal cholestasis","volume":"15","author":"Lee","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21564","article-title":"Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?","volume":"45","author":"Lee","year":"2007","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.ejphar.2015.01.044_bib20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/jgh.12480","article-title":"Beneficial effects of dual VEGFR\/FGFR inhibitor brivanib alaninate in cirrhotic portal hypertensive rats","volume":"29","author":"Lin","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib21","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1073\/pnas.84.21.7696","article-title":"Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors","volume":"84","author":"Lynch","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ejphar.2015.01.044_bib22","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1172\/JCI57734","article-title":"Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease","volume":"121","author":"Ma","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"15\u201316","key":"10.1016\/j.ejphar.2015.01.044_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.lfs.2009.01.023","article-title":"Cilostazol and pentoxifylline decrease angiogenesis, inflammation, and fibrosis in sponge-induced intraperitoneal adhesion in mice","author":"Mendes","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2015.01.044_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.104.004853","article-title":"Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis","volume":"67","author":"Netherton","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib25","first-page":"2478","article-title":"Effect of transforming growth factor \u03b2 on cell death of cultured rat hepatocytes","volume":"51","author":"Oberhammer","year":"1991","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ejphar.2015.01.044_bib26","first-page":"483","article-title":"Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats","volume":"63","author":"Olteanu","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2015.01.044_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/hepr.12140","article-title":"Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis","volume":"44","author":"Saito","year":"2013","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejphar.2015.01.044_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pharmthera.2004.12.001","article-title":"PDE4 inhibitors as new anti inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression","volume":"106","author":"Sanz","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.01.044_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/hep.1840180219","article-title":"Activin induces cell death in hepatocytes in vivo and in vitro","volume":"18","author":"Schwall","year":"1993","journal-title":"J. Hepatol."},{"issue":"23","key":"10.1016\/j.ejphar.2015.01.044_bib30","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0024-3205(99)00157-5","article-title":"OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells","volume":"64","author":"Shimizu","year":"1999","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.ejphar.2015.01.044_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10585-014-9669-y","article-title":"The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy","volume":"31","author":"Strowitzki","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"issue":"14","key":"10.1016\/j.ejphar.2015.01.044_bib32","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.2741\/3529","article-title":"Nuclear receptor ligands in therapy of cholestatic liver disease","volume":"1","author":"Sturm","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2015.01.044_bib33","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2613.2009.00678.x","article-title":"PDEs15 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization","volume":"90","author":"Tahseldar-Roumieh","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.ejphar.2015.01.044_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2010","journal-title":"J. Hepatol."},{"issue":"Suppl. B","key":"10.1016\/j.ejphar.2015.01.044_bib37","doi-asserted-by":"crossref","first-page":"56B","DOI":"10.1016\/S0828-282X(06)70987-4","article-title":"The vascular effects of cilostazol","volume":"22","author":"Weintraub","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2015.01.044_bib38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI116727","article-title":"Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes","volume":"92","author":"Yasuda","year":"1993","journal-title":"J. Clin. Investig."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T13:39:06Z","timestamp":1747575546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":36,"alternative-id":["S0014299915000771"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.044","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}